Xenon Pharmaceuticals XENE reported a loss of 84 cents per share for the fourth quarter of 2024, narrower than the Zacks ...

Xenon Pharmaceuticals (($XENE)) has held its Q4 earnings call. Read on for the main highlights of the call. Xenon Pharmaceuticals’ recent earnings ...

RBC Capital raised the firm’s price target on Xenon Pharmaceuticals (XENE) to $58 from $56 and keeps an Outperform rating on the shares after ...

Xenon Pharmaceuticals Inc (XENE) showcases robust pipeline progress and financial stability, while addressing challenges in ...

Phase 3 topline data from azetukalner FOS epilepsy program planned for H2 2025 in support of NDA filing and potential commercial launch– First ...

BURNABY, British Columbia — BURNABY, British Columbia — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $65.7 million in its fourth quarter. On a per-share basis, the Burnaby, British ...

Recaro has introduced the Xenon 1, a car seat designed to provide superior safety, comfort and convenience for children ages ...

Xenon Pharmaceuticals Inc (NASDAQ:XENE) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 ...

Xenon's discovery concluded an intense period of research on noble gases. Much heavier than neon and krypton, it had not been explicitly predicted, and was sufficiently rare to avoid chance detection.

Research analysts at HC Wainwright lowered their Q1 2025 EPS estimates for Xenon Pharmaceuticals in a report released on Monday, February 24th. HC Wainwright analyst D. Tsao now expects that the ...

Xenon Pharmaceuticals XENE reported a loss of 84 cents per share for the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 89 cents. The company had incurred a loss ...

BURNABY, British Columbia (AP) — BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $65.7 million in its fourth quarter. On a per-share basis ...